Article Details
Retrieved on: 2024-11-11 14:23:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company's cash surplus position remains robust at Rs. 340.6 crore, which is instrumental in supporting further investment in R&D and expanding ...
Article found on: www.indianpharmapost.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here